Changes in body composition during androgen deprivation therapy for prostate cancer.

By Matthew R. Smith, J. Finkelstein, F. Mcgovern, A. Zietman, M. Fallon, D. Schoenfeld, P. Kantoff. Journal of Clinical Endocrinology and Metabolism, 2002

691 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/dcf852da2c11a369992a6462dcd65364fc0a17e1

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. P. Nguyen
2. S. Alibhai
3. D. Galvão
4. S. Basaria
5. A. D'Amico
6. D. Taaffe
7. N. Keating
8. N. Spry

Citations in the corpus

• Adverse effects of androgen deprivation therapy and strategies to mitigate them. (2015, background): “It should be noted that the metabolic profile resulting from ADT differs slightly from the metabolic syndrome in that ADT appears to result in an increase in HDL rather than a decrease, although it is unclear if this has any cardioprotective effect [29].”
• Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. (2010, methodology): “Loss of lean mass after the first year of AST has been extensively documented.(6,32) We previously reported a reduction of 1.”